Literature DB >> 3005364

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.

J W Heinecke, L Baker, H Rosen, A Chait.   

Abstract

Extracellular superoxide was detected in cultures of monkey and human arterial smooth muscle cells as indicated by superoxide dismutase inhibitable reduction of cytochrome c. Superoxide production by these cells in the presence of Fe or Cu resulted in modification of low density lipoprotein (LDL). The degree of LDL modification was directly proportional to the rate of superoxide production by cells. Superoxide dismutase (100 micrograms/ml), and the general free radical scavengers butylated hydroxytoluene and butylated hydroxyanisole (50 microM), inhibited Fe- and Cu-mediated modification of LDL by monkey smooth muscle cells, while catalase (100 micrograms/ml) and mannitol (25 mM) had no effect. The chelators desferrioxamine and diethylenetriamine pentaacetic acid completely inhibited Fe- and Cu-promoted modification of LDL, while EGTA had no inhibitory effect. EDTA stimulated Fe-promoted modification in the 1-100 microM range while inhibiting Cu-mediated modification of LDL. LDL modified by smooth muscle cells in the presence of 10 microM Fe or Cu stimulated [14C]oleate incorporation into cholesteryl ester by human macrophages and murine J774 cells to a degree comparable to that produced by acetylated LDL. LDL incubated with smooth muscle cells and metal ions in the presence of superoxide dismutase failed to enhance macrophage cholesteryl ester accumulation. Thus, arterial smooth muscle cells in culture generate superoxide and modify LDL by a superoxide-dependent, Fe or Cu catalyzed free radical process, resulting in enhanced uptake of the modified LDL by macrophages. Neither hydroxyl radicals nor H2O2 are likely to be involved. Superoxide-dependent lipid peroxidation may contribute to biological modification of LDL, resulting in foam cell formation and atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005364      PMCID: PMC423460          DOI: 10.1172/JCI112371

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

2.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

Authors:  J L Goldstein; Y K Ho; S K Basu; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

3.  Malondialdehyde formation as an indicator of prostaglandin production by human platelets.

Authors:  J B Smith; C M Ingerman; M J Silver
Journal:  J Lab Clin Med       Date:  1976-07

4.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

5.  Enhanced macrophage degradation of biologically modified low density lipoprotein.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Arteriosclerosis       Date:  1983 Mar-Apr

6.  Microsomal lipid peroxidation.

Authors:  J A Buege; S D Aust
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

7.  Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.

Authors:  E Graf; J R Mahoney; R G Bryant; J W Eaton
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

8.  Low density lipoprotein receptor activity in freshly isolated human blood monocytes and lymphocytes.

Authors:  A Chait; K Henze; T Mazzone; M Jensen; W Hammond
Journal:  Metabolism       Date:  1982-07       Impact factor: 8.694

9.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

10.  The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters.

Authors:  M S Brown; Y K Ho; J L Goldstein
Journal:  J Biol Chem       Date:  1980-10-10       Impact factor: 5.157

View more
  56 in total

Review 1.  Biochemical evidence for a link between elevated levels of homocysteine and lipid peroxidation in vivo.

Authors:  J W Heinecke
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

2.  Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.

Authors:  O Jaakkola; T Nikkari
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

3.  Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.

Authors:  M Yang; D S Leake; C A Rice-Evans
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

Review 4.  Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis.

Authors:  B Halliwell
Journal:  Br J Exp Pathol       Date:  1989-12

5.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.

Authors:  S Parthasarathy; E Wieland; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 6.  Interaction of lipoproteins with the artery wall.

Authors:  N Woolf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  The action of defined oxygen-centred free radicals on human low-density lipoprotein.

Authors:  S Bedwell; R T Dean; W Jessup
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

8.  Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans.

Authors:  L R Tannock; P J Little; C Tsoi; P H R Barrett; T N Wight; A Chait
Journal:  Diabetologia       Date:  2004-04-08       Impact factor: 10.122

9.  Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.

Authors:  G Ambrosio; A Oriente; C Napoli; G Palumbo; P Chiariello; G Marone; M Condorelli; M Chiariello; M Triggiani
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  Smoking influences the atherogenic potential of low-density lipoprotein.

Authors:  E Scheffler; E Wiest; J Woehrle; I Otto; I Schulz; L Huber; R Ziegler; H A Dresel
Journal:  Clin Investig       Date:  1992 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.